![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 19, Issue 8, 3379-3389, August 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
*Institute of Parasitology and Biomedicine "López-Neyra," Consejo Superior de Investigaciones Cientificas, 18100 Granada, Spain; Faculty of Life Sciences, The University of Manchester, Manchester M13 9PT, United Kingdom; and Syntaxin Ltd., Abingdon, Oxon OX14 3YS, United Kingdom
Submitted January 9, 2008;
Revised April 30, 2008;
Accepted May 21, 2008
Monitoring Editor: Thomas F. J. Martin
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Hanson et al., 1997; Sutton et al., 1998; Südhof, 2004; Jahn and Scheller, 2006; Rizo et al., 2006; Wojcik and Brose, 2007). Current data suggest that SNARE complex formation proceeds in a vectorial manner from the N-terminal, membrane-distal region toward the C-terminal, membrane-proximal end, which may draw the opposing membranes close enough together for fusion to proceed (Fiebig et al., 1999; Pobbati et al., 2006; Sorensen et al., 2006). Consistent with this, in reconstituted assay systems, SNAREs on their own can support membrane fusion (Weber et al., 1998; Hu et al., 2003; Giraudo et al., 2006; Pobbati et al., 2006).
In intact cells, evoked membrane fusion involves the cooperative action of multiple SNARE complexes (Cull-Candy et al., 1976; Bevan and Wendon, 1984; Stewart et al., 2000). The exact number of complexes required is currently unknown, and estimates vary from three (Hua and Scheller, 2001) to five to eight (Han et al., 2004) to 10–15 (Keller and Neale, 2001; Keller et al., 2004; Montecucco et al., 2005). Such differences may reflect the distinct experimental paradigms used and/or the types of secretory organelles studied. Thus, higher order multimers of SNARE complexes may be required for fast exocytosis of synaptic vesicles, whereas lower order multimers may be sufficient for the slower exocytosis of large dense-core granules from chromaffin and neuroendocrine PC12 cells (Montecucco et al., 2005).
The mechanism(s) responsible for SNARE complex multimerization remains controversial. Initial studies suggested that multimerization of synaptic SNARE complexes could be achieved via domain swapping, whereby one of the two SNAP-25 helices could be substituted by the equivalent helix from a neighboring complex (Kweon et al., 2002). Alternative models proposed the involvement of accessory proteins, such as synaptotagmin (Littleton et al., 2001) or complexin (Tokumaru et al., 2001), or the transmembrane domains of syb2 and syntaxin 1A (Laage et al., 2000), in synaptic SNARE complex multimerization. However, SNARE complexes assembled from recombinant coils and lacking transmembrane domains are able to associate with each other (Fasshauer et al., 1997; Fasshauer et al., 1998; Margittai et al., 2001; Ernst and Brünger, 2003), arguing that at least some of the interactions that support multimerization may require neither accessory proteins nor transmembrane domains. The precise multimeric nature and configuration of these recombinant cytosolic SNARE complexes is ambiguous. Conflicting results have been reported, ranging from dimers involving C-terminal residues of at least one of the two monomers, to mixtures of monomers/trimers in solution (Fasshauer et al., 1997, 1998; Margittai et al., 2001; Ernst and Brünger, 2003). In addition, no investigations have addressed whether such interactions between SNARE complexes might contribute to their biological action.
To test whether multimerization of SNARE complexes mediated by their cytosolic domains is an important step during neurotransmitter release, we first performed a detailed characterization of how such multimers are configured. We identified amino acids within synaptobrevin 2 that contribute to a cytosolic SNARE complex dimer formed with micromolar affinity. Functional analysis of synaptobrevin 2 mutants in which these residues are replaced provides evidence for an important role for SNARE complex dimers during exocytosis.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; also see Supplemental Material). Protein concentrations were estimated by the Bradford assay, and they ranged from 0.3 to 1 mg/ml. SNARE complexes were formed by overnight assembly of equimolar concentrations of purified components in standard buffer and concentrated to 
2 mg/ml. Complex formation was verified by SDS-polyacrylamide gel electrophoresis (PAGE). Determination of synaptotagmin 1 and complexin binding to SNARE complexes was performed as described in Supplemental Material.
Multiangle Laser Light Scattering (MALLS)
SNARE complexes were purified from recombinant coils on a Superdex-200 24/30 gel filtration column (GE Healthcare, Chalfont St. Giles, United Kingdom) run in 5 mM Tris-HCl, pH 7.4, 50 mM NaCl at 0.71 ml/min using a BioLC high-performance liquid chromatography (Dionex, Camberley, United Kingdom). The SNARE complex dimer peak resolved clearly from the mixture. For SNARE complex mutants all molecular weight (MW) analysis refers to that of material within the dimer peak, although some SNARE complex monomer could also be found (data not shown). Protein passed through a Wyatt EOS 18-angle laser photometer (Wyatt Technology, Santa Barbara, CA) with the 13th detector replaced with a QELS detector (Wyatt Technology) for the simultaneous measurement of hydrodynamic radius. This was coupled to an Optilab rEX refractive index detector (Wyatt Technology), and the hydrodynamic radius, molecular weight moments, and concentration of peaks were analyzed using Astra 4.98 (Wyatt Technology).
Analytical Ultracentrifugation
SNARE complex dimers (8 µM) were purified by gel filtration. All experiments were performed in 5 mM Tris-HCl, pH 7.4, containing the indicated concentrations of NaCl, and using a XL-A ultracentrifuge (Beckman Coulter, Fullerton, CA) with an An50Ti 8-hole rotor fitted either with the standard two-sector open-filled centerpieces for sedimentation velocity, or with six-sector Epon-filled centerpieces for equilibrium studies, with quartz glass windows. Velocity sedimentation analysis was performed at 40,000 rpm at 20°C, with the sedimenting boundary monitored at 230 nm every 9 min. Frictional ratios for the monomer and dimer were calculated from the sedimentation coefficient. For data interpretation and solution bead modeling, see Supplemental Material.
Equilibrium sedimentation was performed at 4°C, using rotor speeds of 10, 15, and 21,000 rpm and scanning at 230 nm every 4 h until equilibrium was reached. For molecular weight analysis, data were analyzed with the fitting program HeteroAnalysis by using a single ideal model for a distribution of the mean molecular weight. Data were expressed as the average MW from this approximation (MWapp) relative to the theoretical MW of the monomer. Association constants were investigated using concentrations of 1, 2.5, and 5 µM protein at the same three rotor speeds in 5 mM Tris-HCl and 0.3 M NaCl. Global analysis using Sedphat (developed by Peter Schuck, National Institutes of Health, Bethesda, MA) of a monomer–dimer association produced the best fit.
Small Angle X-Ray Scattering Data Collection
Small angle X-ray solution scattering (SAXS) was carried out using gel filtration-purified SNARE complex dimers (8 µM) on ID02 at the European Synchrotron Radiation Facility (Grenoble, France) by using 1-m and 5-m sample to detector distances. During data collection, the sample was maintained at 10°C. The corresponding profiles were merged so as to cover the momentum transfer interval 0.0038 Å–1 < q < 0.53Å–1. The modulus of the momentum transfer is defined as q = 4
sin
/
, where 2 is the scattering angle, and is the wavelength. With a 1-m camera distance the maximum scattering angle corresponds to a Bragg resolution of 11.8 Å. SAXS patterns were recorded using an image intensified charge-coupled device (CCD) detector having single photon sensitivity and 14 bit dynamic range. The wavelength of X-rays used was 0.1 nm. For further details about data collection and analysis, see Supplemental Material.
Transmission Electron Microscopy (TEM) Single Particle Image Analysis
Gel filtration-purified SNARE complex dimers were concentrated threefold (24 µM), and 5 µl of sample was allowed to adsorb for 30 s onto a glow discharged (25 mA for 30 s) carbon-coated 400 mesh copper grid. The grid was washed three times with MilliQ water (Millipore, Billerica, MA) and then negatively stained with 2% (wt/vol) uranyl acetate, pH 4.7, for 20 s. Grids were observed using a Tecnai Twin TEM (FEI, Hillsboro, OR) equipped with a LaB6 filament operating at 120 keV. Images were recorded under low dose conditions at –600-nm defocus on a 2048 x 2048 CCD camera with a pixel size of 2 Å. The level of defocus of each individual image was checked by inspecting the position of the Thon rings in the power spectra and comparing this to the calculated contrast transfer function. For details on image processing, see Supplemental Materials.
Fluorescence Spectroscopy
SNARE complexes (5 µM) were purified by gel filtration chromatography, and tryptophan fluorescence was measured in a 100-µl, 1-cm path-length cell using an FP750 spectrofluorometer (Jasco, Tokyo, Japan) by excitation at 295 nm and monitoring of emission fluorescence between 300 and 450 nm.
CD Spectroscopy
The CD spectra of SNARE complexes (2–5 µM) purified by gel filtration chromatography were monitored from 260 to 190 nm in 0.2-nm steps (with 10 averages assayed) in a 0.05-cm pathlength cuvette by using a J810 spectropolarimeter (Jasco).
Differential Scanning Calorimetry
The stability of SNARE complexes was investigated using a VP-DSC microcalorimeter (MicroCal, Northampton, MA) with a 0.52-ml total loading volume (also see Supplemental Materials).
FRET Measurements
GFP-tagged SNARE complexes (see Supplemental Materials for details) were purified by gel filtration chromatography (4 µM), and molecular mass was analyzed by MALLS as described above, with a determined mass of 144 ± 4 kDa, close to the predicted mass of 146 kDa for GFP-tagged SNARE complex dimers. Purified C-C– or N-C–tagged SNARE complex dimers were analyzed using a J750 spectrometer (Jasco) and a 100-µl, 1-cm pathlength cell. The excitation wavelength was 433 nm, and emission spectra were measured between 450 and 650 nm in 1-nm steps.
Determination of Localization and Expression Levels of syb2 and of SDS-resistant SNARE Complex Stability
The overexpression levels of nontagged syb2 and mutants thereof, the localization of GFP-tagged syb2 and mutants thereof, and the determination of GFP-tagged SDS-resistant SNARE complex stabilities, were determined as described in Supplemental Material.
Secretion Assays
Confluent PC12 cells were plated onto collagen-coated six-well dishes at 80% confluence, and then they were transfected the following day with 3 µg of DNA by using 10 µl of Lipofectamine 2000 (Invitrogen, Paisley, United Kingdom). Cells were replated into six-well dishes at a ratio of 1:2 the next day, and secretion assays performed two days after replating, with all test and control conditions carried out on the same pool of transfected cells. Controls were treated with 0.6 ml of physiological saline solution (PSS; 145 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM HEPES-NaOH, pH 7.4), and evoked neurosecretion was triggered by a 5-min incubation with high K+ saline solution (PSS containing 95 mM NaCl and 56 mM KCl). The amount of human growth hormone (hGH) in the medium and in cells was determined by an enzyme-linked immunosorbent assay, and the total amount of hGH and the percentage hGH secreted calculated against an hGH standard curve. Statistical analyses were performed with the paired Student's t test.
Toxin Rescue Assays
Release of hGH from toxin-treated, permeabilized PC12 cells transfected with botulinum neurotoxin type B (botB)-resistant syb2 (Q76V,F77W) was measured essentially as described previously (Quetglas et al., 2002) in the presence of recombinantly expressed endopeptidase light chain (LC) of botB (botB/LC). BotB/LC was purified as described previously (Sutton et al., 2005), was of high homogeneity as assessed by SDS-PAGE, and it showed endopeptidase activity comparable with native botulinum neurotoxin by using an in vitro vesicle-associated membrane protein peptide cleavage assay (Sutton et al., 2005). Determination of the cleavage of endogenous syb2 upon toxin treatment, and of the levels of expressed toxin-insensitive syb2 and syb2 mutants, are described in Supplemental Material.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
) reduced the molecular weight to 44,600 Da (Supplemental Figure 2B). Hence, cytosolic neuronal SNARE complexes are quantitatively incorporated into salt-sensitive dimers.
|
|
; Svergun et al., 2001) (Supplemental Figure 3), and the averaged filtered structure resolved as a two-winged particle with each wing 9.5 nm long and tilted at 110° relative to each other (Figure 1B). Using transmission electron microscopy to determine the shape directly revealed a similar structure, with each wing 9–10 nm long and set at 140° to each other (Figure 1C).
To confirm that these shapes are consistent with the observed hydrodynamic properties, bead models were generated from the atomic coordinates within SNARE complexes (Sutton et al., 1998) by using the program SOMO (Spotorno et al., 1997), and then they were aligned in hypothetical configurations and modeled for their hydrodynamic properties. End-to-end dimers set at an angle of 130–140° generated hydrodynamic properties close to those observed experimentally (Figure 1D and Table 1B). Thus, three methods of shape analysis suggest that cytosolic SNARE complexes form uniformly configured dimers, in which the dimerization interface lies close to one end of each SNARE complex and generates an open, two-winged structure.
Orientation of the SNARE Complex Dimer
Fusion of primed vesicles requires conversion of partially assembled trans-SNARE complexes into fully assembled, fusion-competent SNARE bundles (Fiebig et al., 1999; Pobbati et al., 2006; Sorensen et al., 2006). Therefore, a functionally relevant dimer should involve C-terminal SNARE complex regions that lie close to the point of membrane insertion. To address whether the C termini of SNARE complexes are close to each other within a dimer, we measured FRET in SNARE complexes assembled using a mixture of syb2-cyan fluorescent protein (CFP) and syb2-Venus, providing complexes containing either FRET donor or FRET acceptor at the C terminus (Figure 2A). For comparison, SNARE complexes were assembled using syb2-Venus and CFP-syb2. All complexes formed with similar efficiency, and they were equally stable, compared with those containing wild-type (wt) syb2 (data not shown; Supplemental Figure 4). However, only when both FRET partners were located at the C termini of syb2 molecules was a significant FRET signal observed that was sensitive to disruption of the dimer by high salt (Figure 2, B and C). Hence, the C termini of both individual, soluble SNARE complex monomers are adjacent to each other in the dimer. This would suggest that dimers could form in vivo only when SNARE complex assembly is virtually complete.
|
355 nm) at all [NaCl] (Figure 3B, inset), suggesting that the tryptophan residues in both SNARE complex dimers and monomers occupy hydrophilic environments. Thus, the fluorescence decrease upon monomerization most likely results from release of rotational constraints imposed upon at least one tryptophan residue within the dimer and suggests that one or both tryptophans participate in dimerization.
|
|
|
The mutations that we have identified substantially reduce the affinity of SNARE complex dimerization. Importantly, however, they do not affect the stability of each SNARE complex monomer significantly. These formed with identical helicity to wild-type SNARE complexes, assessed by the CD spectroscopy peak at 220 nm (Figure 3D). Differential scanning calorimetry was used to provide a precise estimate of the energy associated with SNARE complex formation and showed that the very high stability of the SNARE complex coiled-coil helix was essentially unaffected by the syb2 dimerization mutations; the melting temperature for all SNARE complexes was very similar and the change in enthalpy associated with this transition was not altered significantly (Figure 3E and Table 2B). Incorporation of syb2(R86A) displayed a slight effect on the stability of individual SNARE complexes (Figure 3E), but importantly, this was not observed when syb2(R86A,W89A,W90A) was used. In summary, our data indicate that three residues of syb2 (R86, W89, and W90) form part of the interaction interface of an open, wing-shaped SNARE complex dimer as observed in solution. In addition, because the two tryptophan residues are fully solvent exposed, the salt sensitivity of the dimer is likely due to salt-dependent changes in its structure, including disruption of salt bridge(s) involving R86.
Syb2 Dimerization Mutants Are Unable to Support Secretion
We next aimed to determine whether residues in syb2 found at the SNARE complex dimer interface in vitro may be important for supporting neurosecretion in vivo. For this purpose, we transfected neuroendocrine PC12 cells with a plasmid containing both syb2 and hGH (Sugita et al., 1999). Cells were then permeabilized and treated with recombinant botulinum neurotoxin type B light-chain (botB/LC) (Sutton et al., 2005), which cleaves and inactivates syb2 (Figure 5A). As expected, Ca2+-dependent secretion of hGH was decreased (to 32% of control) by the presence of botB/LC in cells transfected with a plasmid containing wild-type syb2 (Figure 5B). Such profound, but incomplete inhibition of release has been described previously (Chilcote et al., 1995; Quetglas et al., 2002). The expression of botB/LC-resistant syb2(Q76V,F77W) restored secretion (104% of control) in the presence of toxin (Figure 5B). This rescue assay allowed us to measure the ability of syb2 dimerization mutants to support exocytosis in the absence of endogenous protein. Toxin-insensitive wild-type and mutant syb2 were all expressed to similar degrees (Figure 5C). However, toxin-insensitive syb2(W89A,W90A) was severely impaired in its ability to rescue secretion (17.5% of control) (Figure 5D), similar to what has been described previously (Quetglas et al., 2002). Using this assay system, no further additive effects could be observed using syb2(R86A,W89A,W90A), which was equally deficient in supporting release. Interestingly, syb2(W90A) displayed a slight deficit in its ability to rescue secretion, with syb2(W89A) displaying more pronounced effects (Figure 5D). Hence, the ability of syb2 mutants to support release in vivo reflects the contribution of each corresponding amino acid to the SNARE complex dimer interface. Previous studies have implicated W90 in calmodulin-dependent regulation of exocytosis (Quetglas et al., 2000, 2002). However, because W90A would disrupt the calmodulin binding motif within syb2 (Rhoads and Friedberg, 1997; Chin and Means, 2000), the ability of this mutant to largely support secretion would suggest that such an interaction does not play a major role in vivo.
|
), expression of full-length syb2 mutants that are incorporated into SNARE complexes of normal stability but impaired in dimer formation should generate a dominant-negative phenotype, revealing a potential role for SNARE complex dimerization in membrane fusion.
PC12 cells were transfected with syb2 and hGH as described above, and intact cells were assayed directly to measure constitutive and evoked exocytosis. Exogenous syb2 was expressed at 2–3 times over endogenous levels, and all mutants analyzed were expressed to similar degrees (Figure 6A). Expression of wild-type syb2 did not affect basal or evoked secretion of hGH (data not shown). In contrast, expression of syb2 dimerization mutants reduced evoked secretion without affecting basal secretion or levels of hGH expression (Figure 6B). This inhibition was reproducible, statistically significant, and greatest for syb2(R86A,W89A, W90A), in line with the more pronounced effect of this mutant on SNARE complex dimer stability (Figure 6C). All syb2 constructs analyzed in this study localized to neuritic appendages and were efficiently incorporated with endogenous SNARE proteins into SNARE complex monomers of essentially the same stability, assessed by heating in SDS (Figure 6, E–H, and Supplemental Figures 6 and 7).
|
). Because such interactions may be mutually exclusive with SNARE complex dimerization, we formed SNARE complexes in the presence of complexin 1 or synaptotagmin 1, respectively, and we measured the extent of dimer formation by size exclusion chromatography. SNARE complex dimerization was not prevented by an excess of complexin 1, which coeluted with SNARE complex dimers (Supplemental Figure 8, A and B). Binding was essentially stoichiometric, as judged by the substantial change in apparent molecular weight of dimeric SNARE complexes in the presence of complexin 1. Complexin 1 bound to wild-type and syb2(R86A,W89A,W90A)-containing SNARE complexes with similar efficiency, consistent with complexin binding to a site within the SNARE complex distinct from the dimerization interface. In contrast, the C2AB domain of synaptotagmin 1 could not be detected to bind to SNARE complexes in solution (Supplemental Figure 8C). Whereas it remains formally possible that the lack of synaptotagmin 1 binding is a consequence of SNARE complex dimerization, this is unlikely, because no synaptotagmin 1 binding could be detected, even on overexposed blots, in fractions migrating slightly behind the SNARE complex dimer peak and containing a minor population of SNARE complex monomers (data not shown). Such lack of comigration of soluble synaptotagmin 1 with SNARE complexes during size-exclusion chromatography has been previously observed (Bowen et al., 2005), indicative of a low-affinity interaction in solution. In either case, various structural and mutational data (Chen et al., 2002; Rickman et al., 2006; Lynch et al., 2007) further indicate that residues distinct from those involved in dimerization seem to be responsible for complexin and synaptotagmin binding to SNARE complexes.
W89 and W90 of syb2 have been implicated in binding to phospholipids (Quetglas et al., 2000, 2002; de Haro et al., 2004). In fact, it has been suggested that the reversible insertion of these residues of syb2 into the synaptic vesicle membrane may decrease the availability of syb2 and hence the probability of SNARE complex formation (Hu et al., 2002; Kweon et al., 2003). We therefore also examined SNARE complex dimers formed using a syb2 mutant in which the tryptophans were replaced with hydrophilic serine residues known to support rapid SNARE complex formation (Kweon et al., 2003). Expression of syb2(R86A,W89S, W90S) inhibited evoked secretion to approximately the same level as syb2(R86A,W89A,W90A) (Figure 6C). The stability of dimers formed using this mutant was virtually identical to that formed using syb2(R86A,W89A,W90A) (Figure 3C), and the stability of monomers was essentially the same as wild-type (Figure 3, D and E and Table 2B). Analogous to results obtained using the toxin rescue assay, syb2(W89A) displayed a dominant-negative effect on secretion, whereas syb2(W90A) was without effect (Figure 6D). Hence, the inhibitory effects of the mutants analyzed here are likely not due to interfering with calmodulin and/or phospholipid binding of syb2, as suggested previously (Quetglas et al., 2000, 2002; de Haro et al., 2004), but they are consistent with a mechanism involving impaired SNARE complex multimerization.
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Keller and Neale, 2001; Han et al., 2004; Keller et al., 2004; Montecucco et al., 2005), with the number of participating complexes possibly affecting the speed of opening, or the diameter of the fusion pore (Han et al., 2004). Although oligomerization may be an inherent feature of SNARE complexes, a detailed description of how such interactions take place and their relevance for membrane fusion has been lacking. In this study, we describe and characterize a defined SNARE complex dimer that forms with micromolar affinity in solution in vitro, and provide evidence for its role in neurosecretion in vivo.
The soluble part of SNARE complexes was found to form dimers with the C termini of both monomers interacting at an obtuse angle. This novel and surprising structure is quite distinct from all lattice interactions between neuronal SNARE complex monomers displayed in the crystal structure (Sutton et al., 1998) (PDB entry 1SFC). Although one such crystallographic dimer is formed toward the C termini of both SNARE complex monomers, with W89 of syb2 part of the interaction interface (Supplemental Figure 9), the alignment of monomers along their entire length make this "closed" crystal form distinct from the open, wing-shaped structure of dimers as identified in solution. Hydrodynamic bead modeling of this crystallographic dimer confirms that its hydrodynamic properties are very different from those observed experimentally. In addition, our biochemical and biophysical data strongly indicate the existence of a homogeneous population of dimers. Thus, interactions favored in crystal lattices may not be observed in other contexts (Vestergaard et al., 2005).
Although dimerization between cytosolic domains is likely to play an important role in the multimerization of SNARE complexes, the overall oligomeric status and shape of SNARE complexes in vivo may be further influenced by the juxtaposition of the membrane, the presence of the transmembrane domains, and accessory factors. Indeed, previous studies have shown that native SNARE complexes purified from brain, or SNARE complexes assembled from recombinant full-length SNAREs containing transmembrane domains, assemble into star-shaped particles mostly containing three or four bundles emanating from their center (Rickman et al., 2005). Such structure may be obtained when two dimers associate with each other through their transmembrane domains (Hohl et al., 1998; Laage et al., 2000; Bowen et al., 2002; Roy et al., 2004). Unfortunately, when only one of the two SNAREs carried a transmembrane domain, reassembly experiments led to the generation of large irregular aggregates (Rickman et al., 2005). This makes it difficult to determine the exact contributions of the transmembrane domains and/or membrane-proximal regions of syb2 to the formation of oligomeric structures obtained with full-length SNAREs. Similarly, the need for detergent solubilization precludes analysis of whether identified SNARE complex multimers are present in their trans- or cis-forms, and additional evidence for the existence and importance of SNARE complex oligomers may be best obtained using in vivo approaches.
Earlier studies using syb2(W89A,W90A) had suggested that these residues mediate the binding of syb2 to calmodulin (Quetglas et al., 2002; de Haro et al., 2004). However, no single mutational analysis was performed to corroborate these results. The consensus motif for Ca2+-dependent calmodulin binding involves select hydrophobic residues at positions 1-5-8-14, and an overall net electrostatic charge of +2 to +6 (Rhoads and Friedberg, 1997). As such, W90 is at position 14 of this motif, and a mutation to alanine at this position would not be tolerated (Rhoads and Friedberg, 1997). We find that syb2(W90A) has no effect on secretion either in the presence or absence of endogenous syb2. Similarly, the overall net charge of the calmodulin binding motif within syb2 is +3, and the secretory effect of another mutant (syb2(K83A,K87V)) was suggested to be due to eliminating those charge requirements (Quetglas et al., 2002). However, because K83 is part of the SNARE motif, the effects of this mutant may have been due to altered SNARE complex stability, which was not assessed in sufficient detail. Finally, mutating W89 and W90 to hydrophilic serines does not enhance secretion, as would be expected if the availability of syb2 would be restricted due to its interacting with the hydrophobic part of the phospholipid bilayer (Kweon et al., 2003). Our analysis shows that the ability of syb2 mutants to reduce SNARE complex dimer stability in vitro parallels their inhibition of secretion in vivo. Thus, although we cannot fully exclude compound effects, our data indicate that the secretory effects observed with the syb2 mutants are most likely due to interfering with SNARE complex dimer stability in vivo.
The dimerization of neuronal SNARE complexes may generate an important intermediate during evoked secretion. This intermediate may be transient in vivo, formed after trans-SNARE complex assembly and close to the point of fusion. Although detailed electrophysiological experiments will be needed to determine the precise role of SNARE complex dimers in membrane fusion events, one can speculate from their solution structure how they might contribute toward formation of an oligomeric complex around a fusion pore, consistent with the energies required to bring about membrane fusion (Li et al., 2007). It is interesting to note that the syb2(W89A,W90A) mutant does not seem to be defective in mediating liposomal fusion events (Siddiqui et al., 2007), whereas it profoundly inhibits Ca2+-dependent secretion. Thus, secretory defects using the syb2 dimerization mutants only seem to be evident in cell systems requiring cooperativity between SNARE complexes. Such SNARE complex dimerization may improve the efficiency of vesicle exocytosis by contributing to the cooperative relationship between calcium and synaptic transmission.
|
ACKNOWLEDGMENTS |
|---|
|
Footnotes |
|---|
These authors contributed equally to this work. 
Address correspondence to: Sabine Hilfiker (sabine.hilfiker{at}ipb.csic.es)
Abbreviations used: MALLS, multiangle laser light scattering; SAXS, small angle X-ray scattering; SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein receptor; syb2, synaptobrevin 2; TEM, transmission electron microscopy.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Bevan, S., and Wendon, L. M. (1984). A study of the action of tetanus toxin at rat soleus neuromuscular junctions. J. Physiol 348, 1–17.
Bowen, M. E., Engelman, D. M., and Brunger, A. T. (2002). Mutational analysis of synaptobrevin transmembrane domain oligomerization. Biochemistry 41, 15861–15866.[CrossRef][Medline]
Bowen, M. E., Weninger, K., Ernst, J., Chu, S., and Brunger, A. T. (2005). Single-molecule studies of synaptotagmin and complexin binding to the SNARE complex. Biophys. J 89, 690–702.[CrossRef][Medline]
Chen, X., Tomchick, D. R., Kovrigin, E., Arac, D., Machius, M., Südhof, T. C., and Rizo, J. (2002). Three-dimensional structure of the complexin/SNARE complex. Neuron 33, 397–409.[CrossRef][Medline]
Chilcote, T. J., Galli, T., Mundigl, O., Edelmann, L., McPherson, P. S., Takei, K., and De Camilli, P. (1995). Cellubrevin and synaptobrevins: similar subcellular localization and biochemical properties in PC12 cells. J. Cell Biol 129, 219–231.
Chin, D., and Means, A. R. (2000). Calmodulin: a prototypical calcium sensor. Trends Cell Biol 10, 322.[CrossRef][Medline]
Cull-Candy, S. G., Lundh, H., and Thesleff, S. (1976). Effects of botulinum toxin on neuromuscular transmission in the rat. J. Physiol 260, 177–203.
de Haro, L., Ferracci, G., Opi, S., Iborra, C., Quetglas, S., Miquelis, R., Leveque, C., and Seagar, M. (2004). Ca2+/calmodulin transfers the membrane-proximal lipid-binding domain of the v-SNARE synaptobrevin from cis to trans bilayers. Proc. Natl. Acad. Sci. USA 101, 1578–1583.
Ernst, J. A., and Brünger, A. T. (2003). High resolution structure, stability, and synaptotagmin binding of a truncated neuronal SNARE complex. J. Biol. Chem 278, 8630–8636.
Fasshauer, D., Eliason, W. K., Brünger, A. T., and Jahn, R. (1998). Identification of a minimal core of the synaptic SNARE complex sufficient for reversible assembly and disassembly. Biochemistry 37, 10354–10362.[CrossRef][Medline]
Fasshauer, D., Otto, H., Eliason, W. K., Jahn, R., and Brünger, A. T. (1997). Structural changes are associated with soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor complex formation. J. Biol. Chem 272, 28036–28041.
Fiebig, K. M., Rice, L. M., Pollock, E., and Brünger, A. T. (1999). Folding intermediates of SNARE complex assembly. Nat. Struct. Biol 6, 117–123.[CrossRef][Medline]
Giraudo, C. G., Eng, W. S., Melia, T. J., and Rothman, J. E. (2006). A clamping mechanism involved in SNARE-dependent exocytosis. Science 313, 676–680.
Han, X., Wang, C. T., Bai, J., Chapman, E. R., and Jackson, M. B. (2004). Transmembrane segments of syntaxin line the fusion pore of Ca2+-triggered exocytosis. Science 304, 289–292.
Hanson, P. I., Roth, R., Morisaki, R., Jahn, R., and Heuser, J. E. (1997). Structure and conformational changes in NSF and its membrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy. Cell 90, 523–536.[CrossRef][Medline]
Hohl, T. M., Parlati, F., Wimmer, C., Rothman, J. E., Söllner, T. H., and Engelhardt, H. (1998). Arrangement of subunits in 20S particles consisting of NSF, SNAPs, and SNARE complexes. Mol. Cell 2, 539–548.[CrossRef][Medline]
Hu, C., Ahmed, M., Melia, T. J., Söllner, T., Mayer, T., and Rothman, J. E. (2003). Fusion of cells by flipped SNAREs. Science 300, 1745–1749.
Hu, K., Carroll, J., Fedorovich, S., Rickman, C., Sukhodub, A., and Davletov, B. (2002). Vesicular restriction of synaptobrevin suggests a role for calcium in membrane fusion. Nature 415, 646–650.[CrossRef][Medline]
Hua, Y., and Scheller, R. H. (2001). Three SNARE complexes cooperate to mediate membrane fusion. Proc. Natl. Acad. Sci. USA 98, 8065–8070.
Jahn, R., and Scheller, R. H. (2006). SNAREs-engines for membrane fusion. Nat. Rev. Mol. Cell Biol 7, 631–643.[CrossRef][Medline]
Keller, J. E., Cai, F., and Neale, E. A. (2004). Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 43, 526–532.[CrossRef][Medline]
Keller, J. E., and Neale, E. A. (2001). The role of the synaptic protein SNAP-25 in the potency of botulinum neurotoxin type A. J. Biol. Chem 276, 13476–13482.
Kweon, D. H., Chen, Y., Zhang, F., Poirier, M., Kim, C. S., and Shin, Y. K. (2002). Probing domain swapping for the neuronal SNARE complex with electron paramagnetic resonance. Biochemistry 41, 5449–5452.[CrossRef][Medline]
Kweon, D.-H., Kim, C. S., and Shin, Y.-K. (2003). Regulation of neuronal SNARE assembly by the membrane. Nat. Struct. Biol 10, 440–447.[CrossRef][Medline]
Laage, R., Rohde, J., Brosig, B., and Langosch, D. (2000). A conserved membrane-spanning amino acid motif drives homomeric and supports heteromeric assembly of presynaptic SNARE proteins. J. Biol. Chem 275, 17481–17487.
Li, F., Pincet, F., Perez, E., Eng, W. S., Melia, T. J., Rothman, J. E., and Tareste, D. (2007). Energetics and dynamics of SNAREpin folding across lipid bilayers. Nat. Struct. Mol. Biol 14, 890–896.[CrossRef][Medline]
Littleton, J. T., Bai, J., Vyas, B., Desai, R., Baltus, A. E., Garment, M. B., Carlson, S. D., Ganetzky, B., and Chapman, E. R. (2001). Synaptotagmin mutants reveal essential functions for the C2B domain in Ca2+-triggered fusion and recycling of synaptic vesicles in vivo. J. Neurosci 21, 1421–1433.
Lynch, K. L., Gerona, R.R.L., Larsen, E. C., Marcia, R. F., Mitchell, J. C., and Martin, T.F.J. (2007). Synaptotagmin C2A loop 2 mediates Ca2+-dependent SNARE interactions essential for Ca2+-triggered vesicle exocytosis. Mol. Biol. Cell 18, 4957–4968.
Margittai, M., Fasshauer, D., Pabst, S., Jahn, R., and Langen, R. (2001). Homo- and heterooligomeric SNARE complexes studied by site-directed spin labeling. J. Biol. Chem 276, 13169–13177.
Montecucco, C., Schiavo, G., and Pantano, S. (2005). SNARE complexes and neuroexocytosis: how many, how close? Trends Biochem. Sci 30, 367.[CrossRef][Medline]
Pobbati, A. V., Stein, A., and Fasshauer, D. (2006). N- to C-terminal SNARE complex assembly promotes rapid membrane fusion. Science 313, 673–676.
Quetglas, S., Iborra, C., Sasakawa, N., De Haro, L., Kumakura, K., Sato, K., Leveque, C., and Seagar, M. (2002). Calmodulin and lipid binding to synaptobrevin regulates calcium-dependent exocytosis. EMBO J 21, 3970–3979.[CrossRef][Medline]
Quetglas, S., Leveque, C., Miquelis, R., Sato, K., and Seagar, M. (2000). Ca2+-dependent regulation of synaptic SNARE complex assembly via a calmodulin- and phospholipid-binding domain of synaptobrevin. Proc. Natl. Acad. Sci. USA 97, 9695–9700.
Rhoads, A. R., and Friedberg, F. (1997). Sequence motifs for calmodulin recognition. FASEB J 11, 331–340.[Abstract]
Rickman, C., Hu, K., Carroll, J., and Davletov, B. (2005). Self-assembly of SNARE fusion proteins into star-shaped oligomers. Biochem. J 388, 75–79.[CrossRef][Medline]
Rickman, C., Jiménez, J. L., Graham, M. E., Archer, D. A., Soloviev, M., Burgoyne, R. D., and Davletov, B. (2006). Conserved prefusion protein assembly in regulated exocytosis. Mol. Biol. Cell 17, 283–294.
Rizo, J., Chen, X., and Arac, D. (2006). Unraveling the mechanisms of synaptotagmin and SNARE function in neurotransmitter release. Trends Cell Biol 16, 339.[CrossRef][Medline]
Roy, R., Laage, R., and Langosch, D. (2004). Synaptobrevin transmembrane domain dimerization-revisited. Biochemistry 43, 4964–4970.[CrossRef][Medline]
Siddiqui, T. J., Vites, O., Stein, A., Heintzmann, R., Jahn, R., and Fasshauer, D. (2007). Determinants of synaptobrevin regulation in membranes. Mol. Biol. Cell 18, 2037–2046.
Sorensen, J. B., Wiederhold, K., Muller, E. M., Milosevic, I., Nagy, G., de Groot, B. L., Grubmuller, H., and Fasshauer, D. (2006). Sequential N- to C-terminal SNARE complex assembly drives priming and fusion of secretory vesicles. EMBO J 25, 955–966.[CrossRef][Medline]
Spotorno, B., Piccinini, L., Tassara, G., Ruggiero, C., Nardini, M., Molina, F., and Rocco, M. (1997). BEAMS (BEAds Modelling System): a set of computer programs for the generation, the visualization and the computation of the hydrodynamic and conformational properties of bead models of proteins. Eur. Biophys. J 25, 373–384.[CrossRef]
Stewart, B. A., Mohtashami, M., Trimble, W. S., and Boulianne, G. L. (2000). SNARE proteins contribute to calcium cooperativity of synaptic transmission. Proc. Natl. Acad. Sci. USA 97, 13955–13960.
Südhof, T. C. (2004). The synaptic vesicle cycle. Annu. Rev. Neurosci 27, 509–547.[CrossRef][Medline]
Sugita, S., Janz, R., and Südhof, T. C. (1999). Synaptogyrins regulate Ca2+-dependent exocytosis in PC12 cells. J. Biol. Chem 274, 18893–18901.
Sutton, J. M., Wayne, J., Scott-Tucker, A., O'Brien, S. M., Marks, P. M., Alexander, F. C., Shone, C. C., and Chaddock, J. A. (2005). Preparation of specifically activatable endopeptidase derivatives of Clostridium botulinum toxins type A, B, and C and their applications. Protein Expr. Purif 40, 31–41.[CrossRef][Medline]
Sutton, R. B., Fasshauer, D., Jahn, R., and Brünger, A. T. (1998). Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4Å resolution. Nature 395, 347–353.[CrossRef][Medline]
Svergun, D. I. (1999). Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J 76, 2879–2886.[Medline]
Svergun, D. I., Petoukhov, M. V., and Koch, M. H. (2001). Determination of domain structure of proteins from X-ray solution scattering. Biophys. J 80, 2946–2953.[Medline]
Söllner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H., and Rothman, J. E. (1993). A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell 75, 409–418.[CrossRef][Medline]
Tang, J., Maximov, A., Shin, O., Dai, H., Rizo, J., and Südhof, T. C. (2006). A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis. Cell 126, 1175–1187.[CrossRef][Medline]
Tokumaru, H., Umayahara, K., Pellegrini, L., Ishizuka, T., Saisu, H., Betz, H., Augustine, G., and Abe, T. (2001). SNARE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis. Cell 104, 421–432.[CrossRef][Medline]
Vestergaard, B., Sanyal, S., Roessle, M., Mora, L., Buckingham, R. H., Kastrup, J. S., Gajhede, M., Svergun, D. I., and Ehrenberg, M. (2005). The SAXS solution structure of RF1 differs from its crystal structure and is similar to its ribosome bound cryo-EM structure. Mol. Cell 20, 929–938.[CrossRef][Medline]
Weber, T., Zemelman, B. V., McNew, J. A., Westermann, B., Gmachl, M., Parlati, F., Söllner, T. H., and Rothman, J. E. (1998). SNAREpins: minimal machinery for membrane fusion. Cell 92, 759–772.[CrossRef][Medline]
Wojcik, S. M., and Brose, N. (2007). Regulation of membrane fusion in synaptic excitation-secretion coupling: speed and accuracy matter. Neuron 55, 11–24.[CrossRef][Medline]
This article has been cited by other articles:
|
|
 |
|
  E. Rubio de la Torre, B. Luzon-Toro, I. Forte-Lago, A. Minguez-Castellanos, I. Ferrer, and S. Hilfiker Combined kinase inhibition modulates parkin inactivation Hum. Mol. Genet., March 1, 2009; 18(5): 809 - 823. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Helical content using CD spectroscopy (R86A,W89S,W90S mutant not determined). (e) SNARE complex melting temperature using differential scanning calorimetry.
